GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Policy Acquisition Expense

Legend Biotech (FRA:9LB) Policy Acquisition Expense


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Legend Biotech (FRA:9LB) Business Description

Traded in Other Exchanges
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.